XB-IMG-145171
Xenbase Image ID: 145171
|
Fig. 8.
ERF gain of function leads to precocious neurogenesis under appropriate conditions. (A-L) All embryos were injected unilaterally with 0.1 ng hGR-Erf (S246,251 A246,251) mRNA at the two- or four-cell stage, then treated with 10 μM dexamethasone (DEX) or 0.1% DMSO vehicle at various stages. The injected side is indicated by the magenta β-gal mRNA lineage tracer. (A,D,G,J) DMSO-treated embryos. (B) Dexamethasone treatment at stage 9 produced reduction of N-tubulin in 40% of embryos. (E) Dexamethasone treatment at stage 10.5 produced precocious neurogenesis in 28% of embryos. (H) Dexamethasone treatment at stage 11 produced precocious neurogenesis in 27% of embryos. (K) Embryos treated with dexamethasone at stage 11.5 were mostly unchanged. The red arrows indicate the increase in N-tubulin expression. (C,F,I,L) Scoring of embryos in A-K: LT, low tubulin; PMN, premature neurogenesis; ESN, extra sensory neurons; NC, no change. All embryos are shown in dorsal view with anterior at the bottom, at stage 13/13.5. Image published in: Janesick A et al. (2013) Copyright © 2013. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.
Image source: Published Larger Image Printer Friendly View |